nimodipine has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lozupone, M | 1 |
| La Montagna, M | 1 |
| D'Urso, F | 1 |
| Piccininni, C | 1 |
| Sardone, R | 1 |
| Dibello, V | 1 |
| Giannelli, G | 1 |
| Solfrizzi, V | 1 |
| Greco, A | 1 |
| Daniele, A | 1 |
| Quaranta, N | 1 |
| Seripa, D | 1 |
| Bellomo, A | 1 |
| Logroscino, G | 1 |
| Panza, F | 1 |
1 review available for nimodipine and Depressive Disorder, Treatment-Resistant
| Article | Year |
|---|---|
Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorder.
Topics: Alzheimer Disease; Antipsychotic Agents; Calcium Channel Blockers; Clinical Trials as Topic; Depress | 2018 |